Product Description
Amifostine is used protect the kidneys from harmful effects of the chemotherapy drug cisplatin in patients that receive this medication for the treatment of ovarian cancer. Amifostine is also used to decrease dryness in the mouth caused by radiation treatment after surgery for head and neck cancer. Amifostine is in a class of medications called cytoprotectants. It works by protecting against the harmful effects of chemotherapy medications and radiation treatment. (Sourced from: https://medlineplus.gov/druginfo/meds/a696014.html)
Mechanisms of Action: Cisplatin Antagonist, Free Radical Antagonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Intravenous
FDA Designation: *
Approval Status: Approved
Approved Countries: Australia | Brazil | Canada | Chile | Colombia | Cyprus | Dominican Republic | Ecuador | France | Germany | Greece | India | Italy | Mexico | New Zealand | Pakistan | Peru | Portugal | Russia | South Africa | Spain | Sweden | Switzerland | Taiwan | Thailand | Turkey | United Kingdom | United States | Venezuela
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
10/04/2023 |
News Article |
Roll Your Own Cigarett Market Outlooks 2023 Size, Cost Structures, Growth rate Forecast to 2031 |
|
10/03/2023 |
News Article |
[2023-2031] Baseball Helmets Market Development Stats, Industry Planning Structure |
|
09/19/2023 |
News Article |
[2023-2030] Amifostine Market CAGR at 2.89 percent,Size, Research Report |
|
09/19/2023 |
News Article |
Stainless Steel Flanges Market 2023 CAGR at 4.8 percent, Demand, Growth, Research Report 2030 |